New Hope's ROE Reaches 17%, Driving Stock Up 3.8%
- Return on Equity Analysis: New Hope's return on equity (ROE) stands at 17%, surpassing the industry average of 11%, indicating the company's strong performance in capital utilization, which enhances investor confidence in its long-term financial health.
- Earnings Growth Potential: Over the past five years, New Hope has achieved a net income growth rate of 25%, comparable to the industry average of 26%, showcasing the company's robust performance in profitability and market competitiveness, likely attracting more investor interest.
- Earnings Retention Strategy: With a three-year median payout ratio of 48%, New Hope demonstrates effective profit retention while continuing to pay dividends, enhancing its financial stability and future growth potential.
- Future Outlook: Although the ROE is expected to decline to 12%, the company plans to maintain a payout ratio of 52%, reflecting its commitment to shareholder returns while also indicating a cautious outlook on future earnings growth.
Trade with 70% Backtested Accuracy
Analyst Views on NHC
About NHC
About the author
National Healthcare Declares Quarterly Dividend of $0.64
- Quarterly Dividend Announcement: National Healthcare has declared a quarterly dividend of $0.64 per share, consistent with previous distributions, indicating stable cash flow and profitability, which is likely to attract more investor interest.
- Payment Schedule: The dividend is payable on April 30, with a record date of March 31 and an ex-dividend date also on March 31, providing shareholders with a clear timeline that helps boost shareholder confidence.
- Dividend Growth Potential: The dividend scorecard and yield chart indicate that National Healthcare has achieved a 50% return over the past six months, while still being considered undervalued, which may attract income-seeking investors looking for stable returns.
- Quant Rating Support: Seeking Alpha's quant rating on National Healthcare further supports its investment value, suggesting the company's competitiveness and future growth potential in the market, which could lead to further stock price appreciation.
New Hope's ROE Reaches 17%, Driving Stock Up 3.8%
- Return on Equity Analysis: New Hope's return on equity (ROE) stands at 17%, surpassing the industry average of 11%, indicating the company's strong performance in capital utilization, which enhances investor confidence in its long-term financial health.
- Earnings Growth Potential: Over the past five years, New Hope has achieved a net income growth rate of 25%, comparable to the industry average of 26%, showcasing the company's robust performance in profitability and market competitiveness, likely attracting more investor interest.
- Earnings Retention Strategy: With a three-year median payout ratio of 48%, New Hope demonstrates effective profit retention while continuing to pay dividends, enhancing its financial stability and future growth potential.
- Future Outlook: Although the ROE is expected to decline to 12%, the company plans to maintain a payout ratio of 52%, reflecting its commitment to shareholder returns while also indicating a cautious outlook on future earnings growth.
NHC Declares Standard Dividend
Dividend Announcement: National HealthCare Corporation (NHC) will pay a quarterly dividend of 64 cents per share to shareholders on record as of December 31, 2025, with payment scheduled for January 30, 2026.
Forward-Looking Statements: NHC warns that forward-looking statements in the press release involve risks and uncertainties, which are detailed in their SEC filings, including potential liabilities, economic conditions, and regulatory changes.
Company Overview: As of August 1, 2025, NHC operates 80 skilled nursing facilities, 26 assisted living communities, and various other healthcare services, totaling over 12,000 beds and units across its facilities.
Additional Information: More details about NHC and its services can be found on their website at www.nhccare.com.
NHC Crosses Above Key Moving Average Level
Stock Performance Overview: NHC's stock has a 52-week low of $89.14 and a high of $137.53, with the last trade recorded at $104.01.
Disclaimer on Opinions: The views expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
National HealthCare Corp. Reveals Drop In Q2 Bottom Line
Earnings Decline: National HealthCare Corp. reported a profit of $23.722 million for the second quarter, down from $26.844 million in the same period last year, resulting in earnings per share of $1.52 compared to $1.73.
Revenue Growth: Despite the decline in profit, the company's revenue increased by 24.7% to $374.910 million, up from $300.658 million in the previous year.
Healthcare's 2025 Stock Crash Could Be A 2030 Windfall
Healthcare Sector Performance: In 2025, the healthcare sector has underperformed with a negative return of 1.3%, primarily due to regulatory pressures and trade tensions, while the S&P 500 has gained 8.4%.
Long-Term Growth Potential: Despite current challenges, the aging U.S. population presents significant future demand for healthcare services, making it a potentially lucrative investment area for those willing to adopt a long-term perspective.
National Healthcare Declares Quarterly Dividend of $0.64
- Quarterly Dividend Announcement: National Healthcare has declared a quarterly dividend of $0.64 per share, consistent with previous distributions, indicating stable cash flow and profitability, which is likely to attract more investor interest.
- Payment Schedule: The dividend is payable on April 30, with a record date of March 31 and an ex-dividend date also on March 31, providing shareholders with a clear timeline that helps boost shareholder confidence.
- Dividend Growth Potential: The dividend scorecard and yield chart indicate that National Healthcare has achieved a 50% return over the past six months, while still being considered undervalued, which may attract income-seeking investors looking for stable returns.
- Quant Rating Support: Seeking Alpha's quant rating on National Healthcare further supports its investment value, suggesting the company's competitiveness and future growth potential in the market, which could lead to further stock price appreciation.
New Hope's ROE Reaches 17%, Driving Stock Up 3.8%
- Return on Equity Analysis: New Hope's return on equity (ROE) stands at 17%, surpassing the industry average of 11%, indicating the company's strong performance in capital utilization, which enhances investor confidence in its long-term financial health.
- Earnings Growth Potential: Over the past five years, New Hope has achieved a net income growth rate of 25%, comparable to the industry average of 26%, showcasing the company's robust performance in profitability and market competitiveness, likely attracting more investor interest.
- Earnings Retention Strategy: With a three-year median payout ratio of 48%, New Hope demonstrates effective profit retention while continuing to pay dividends, enhancing its financial stability and future growth potential.
- Future Outlook: Although the ROE is expected to decline to 12%, the company plans to maintain a payout ratio of 52%, reflecting its commitment to shareholder returns while also indicating a cautious outlook on future earnings growth.
NHC Declares Standard Dividend
Dividend Announcement: National HealthCare Corporation (NHC) will pay a quarterly dividend of 64 cents per share to shareholders on record as of December 31, 2025, with payment scheduled for January 30, 2026.
Forward-Looking Statements: NHC warns that forward-looking statements in the press release involve risks and uncertainties, which are detailed in their SEC filings, including potential liabilities, economic conditions, and regulatory changes.
Company Overview: As of August 1, 2025, NHC operates 80 skilled nursing facilities, 26 assisted living communities, and various other healthcare services, totaling over 12,000 beds and units across its facilities.
Additional Information: More details about NHC and its services can be found on their website at www.nhccare.com.
NHC Crosses Above Key Moving Average Level
Stock Performance Overview: NHC's stock has a 52-week low of $89.14 and a high of $137.53, with the last trade recorded at $104.01.
Disclaimer on Opinions: The views expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
National HealthCare Corp. Reveals Drop In Q2 Bottom Line
Earnings Decline: National HealthCare Corp. reported a profit of $23.722 million for the second quarter, down from $26.844 million in the same period last year, resulting in earnings per share of $1.52 compared to $1.73.
Revenue Growth: Despite the decline in profit, the company's revenue increased by 24.7% to $374.910 million, up from $300.658 million in the previous year.
Healthcare's 2025 Stock Crash Could Be A 2030 Windfall
Healthcare Sector Performance: In 2025, the healthcare sector has underperformed with a negative return of 1.3%, primarily due to regulatory pressures and trade tensions, while the S&P 500 has gained 8.4%.
Long-Term Growth Potential: Despite current challenges, the aging U.S. population presents significant future demand for healthcare services, making it a potentially lucrative investment area for those willing to adopt a long-term perspective.
